Search Results for "Odac Marqibo 2012"

17:20 EDT 3rd August 2015 | BioPortfolio

Matching Channels

macitentan

Macitentan (Opsumit®) is a novel dual endothelin receptor antagonist (ERA) that resulted from a tailored drug discovery process with the target to develop an ERA optimized for efficacy and safet...

ATX-MS-1467 for patients with multiple sclerosis (MS)

ATX-MS-1467 is a novel treatment that was developed with the aim of working with the immune system to treat the underlying cause of disease rather than just treating the symptoms or suppressing the ...

Coronavirus

Coronavirus were first identified in the 1960s, and were named after the crown-like projections on the surface of the virus. They cause respiratory infections in both humans and animals. Coronavir...

Veregen

Veregen® is an ointment used to treat external genital warts. In the USA, Germany, Austria, Spain, Switzerland and Serbia, Veregen® is already marketed by our partners. Sales and marketing p...

PATHSEEK

Sequencing platforms in diagnostic laboratories may aid both patient management by detecting resistance associated mutations, and public health measures, by determining phylogenetic relationships be...

Matching News

Latest News From "The Pink Sheet" DAILY - Aveo's Tivozanib Faces ODAC May 2

Aveo's Tivozanib Will Face Challenging Survival Data At ODAC Review FDA's Oncologic Drugs Advisory Committee will consider the tyrosine kinase inhibitor for advanced renal cell carcinoma at a May 2 me...

From Advisory Committee to Approval: FDA Makes Move to Approve a First US Biosimilar Medicine

The Food and Drug Administration (FDA) approved Zarxio (filgrastim-sndz), the first biosimilar product (or biosimilar), on March 6, 2015, making for a quick approval decision following the January 7, ...

FDA panel backs Amgen's T-Vec, with caveats

At the joint meeting of the FDA's Cellular, Tissue and Gene Therapies (CTGTAC) and Oncologic Drugs (ODAC) Advisory Committees, the panel voted 22-1 that T-Vec has an overall favorable benefit-risk pro...

Melanoma Vaccine May Be Approved By October

The US Food and Drug Administration's (FDA) Cellular, Tissue, and Gene Therapies Advisory Committee (CTGTAC) and Oncologic Drugs Advisory Committee (ODAC) are giving the green light to a new cancer im...

Inflammatory Breast Cancer: What is It, and Who Gets It?

_kmq.push(["trackClickOnOutboundLink","wpa2a_80","Article link clicked",{"Title":"","Page":"Inflammatory Breast Cancer: What is It, and Who Gets It?"}]);While inflammatory breast cancer (IBC) is a par...

Proposed Fund for 2012 Meningitis Victims Up to $210M

A compensation fund for victims of a nationwide fungal meningitis outbreak blamed on a tainted steroid has grown to $210 million.   The 2012 outbreak killed 64 people and sickened more than 750 in ...

Genentech:Napoleone Ferrara, Winner of The Economist's Bioscience Innovation Award 2012

In this episode of PharmaTelevision News Review, filmed at The Economist's Innovation Awards 2012 at BAFTA in London, Fintan Walton talks to Napoleone Ferrara of Genentech, winner of the 2012 Bioscien...

Morphosys AG - EMA 200 als Unterstützung bereit!

Liebe Trader, zwischen Anfang 2006 und September 2012 tendierte das Papier der Morphosys AG knapp unterhalb der Hürde von 20,00 EUR lange Zeit seitwärts. Erst gegen Ende 2012, bei Ausbruch der Kurs....

Matching PubMed Articles

Influenza in Poland in 2011-2012 and in 2011/2012 and 2012/2013 epidemic seasons.

This paper aimed at evaluating the epidemiological situation of influenza in Poland in 2011-2012 and in 2011/2012 and 2012/2013 epidemic seasons and comparing it with the situation observed in the pre...

Drinking Patterns in US Counties From 2002 to 2012.

We estimated the prevalence of any drinking and binge drinking from 2002 to 2012 and heavy drinking from 2005 to 2012 in every US county.

Registered report: Transcriptional amplification in tumor cells with elevated c-Myc.

The Lin et al. (2012), published in Cell in 2012. The experiments that will be replicated are those reported in Figures 3E and 3F. In these experiments, elevated levels of c-Myc in the P493-6 cell mod...

Trends in Elevated Triglyceride in Adults: United States, 2001-2012.

The percentage of adults aged 20 and over with elevated triglyceride (150 mg/dL or more) declined from 33.3% during 2001-2004 to 25.1% during 2009-2012. Percentages with elevated triglyceride decrease...

(13)C Nuclear Magnetic Resonance and Electron Paramagnetic Spectroscopic Comparison of Hydrophobic Acid, Transphilic Acid, and Reverse Osmosis May 2012 Isolates of Organic Matter from the Suwannee River.

Dissolved organic matter (DOM) is found in most natural waters at concentrations low enough to make DOM isolation methodologies critical to full analytical characterization and preservation. During th...

Search Whole site using Google

Loading

Advertisement
 
Advertisement
 
Advertisement Advertisement